| MTS, Oaktree Announce the Formation of Novis Pharmaceuticals, LLC
NEW YORK--(BUSINESS WIRE)--MTS Health Investors, LLC ("MTS") and Oaktree Capital Management, LLC ("Oaktree") today announced the formation of Novis Pharmaceuticals, LLC, a new company that will distribute biotherapeutic products to healthcare providers. Funds under the management of MTS and Oaktree formed Novis Pharmaceuticals and provided equity capital for the new company and its acquisition of certain assets of a specialty drug distributor. This transaction positions Novis Pharmaceuticals as a leading national distributor of some of the world's leading plasma-derived products such as albumin, immune globulin, hyperimmunes and anti-hemophilic Factors VII, VIII and IX. Hospitals, home infusion therapy companies and other healthcare providers use these biotherapeutics to treat trauma, autoimmune conditions, immune deficiencies, infectious diseases, bleeding disorders, and other life-threatening conditions.
What's new Faux cigarette may help in quitting
Participants in smoking- cessation classes at St. John's Health System in Anderson have a new tool to help them fight the tobacco habit -- a fake cigarette that provides them with some of the same sensations as their favorite drag without the smoke or nicotine. .
Valencia, in Barcelona's Shadow, May Be First Spain Soccer IPO
April 10 (Bloomberg) -- Valencia is considering becoming the first Spanish soccer team to sell shares to investors following public offerings by Italy's Juventus and France's Lyon, President Juan Bautista Soler said. ``We could become stock-market listed; it's a possibility, that's where the future is,'' Soler, a property developer who owns 33 percent of the club, said in an interview. ``There are a lot of investment funds that want part of their portfolio in sports.'' Valencia, the last remaining Spanish club in Europe's Champions League this season, is in a better position to sell shares than Real Madrid and Barcelona because its bigger rivals are owned by their fans and have repeatedly rejected the possibility of having their shares publicly traded. Valencia plays London's Chelsea today for a place in the semifinals of Europe's richest club competition.
Altadis Rejects New $16 Billion Offer From Imperial (Update5)
April 10 (Bloomberg) -- Altadis SA, the maker of Gauloises cigarettes, rejected a sweetened takeover bid by Imperial Tobacco Group Plc that values the company at 12 billion euros ($16 billion), saying the price is still too low. The new offer of 47 euros a share that Imperial Tobacco proposed isn't high enough, Madrid-based Altadis said in a regulatory filing today. The offer is 1.5 percent below the closing price on April 5, the last day the shares traded. Altadis turned down the first offer, of 45 euros a share, on March 16. Buying Altadis would give Imperial the Fortuna cigarette brand and the world's biggest cigar company as government crackdowns cause its main markets to shrink. Imperial Tobacco would gain the Marquise brand in Morocco, where Altadis owns the monopoly tobacco distributor and smoking is increasing.
|
